MARYAM FATHI: Open Payments
NPI 1457088247 · WEST HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,730 in 89 payments from 11 companies in 2025. Trend: 2023 $1,448 · 2024 $1,476 · 2025 $2,730
Food & beverage: $2,646Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 15 | $540 |
| Janssen Biotech, Inc. | 10 | $508 |
| Phathom Pharmaceuticals, Inc. | 9 | $405 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $273 |
| ABBVIE INC. | 16 | $258 |
| Ardelyx, Inc. | 8 | $213 |
| Novo Nordisk Inc | 4 | $183 |
| GENZYME CORPORATION | 5 | $160 |
| PFIZER INC. | 4 | $112 |
| QOL Medical, LLC | 2 | $47 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, XIFAXAN, LINZESS, IBSRELA, Wegovy, DUPIXENT.
Industry payments across CA — which companies pay providers there.
